HOOKIPA Pharma Inc. (HOOK) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	14.2	18.4	19.6	11.9	7.6	0.0
Revenue growth	-22.8%	-5.8%	64.0%	56.5%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	14.2	18.4	19.6	11.9	7.6	0.0
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%
Selling, general and administrative [+]	18.8	17.3	18.1	16.7	6.8	4.4
General and administrative	18.8	17.3	18.1	16.7	6.8	4.4
Research and development	68.6	82.9	54.8	46.3	22.0	9.8
EBITDA [+]	-69.6	-77.0	-49.1	-48.0	-20.5	-13.8
EBITDA growth	-9.7%	56.8%	2.3%	133.8%	49.3%
EBITDA margin	-488.1%	-417.6%	-250.9%	-402.1%	-269.2%
Depreciation and amortization	3.6	4.6	4.2	3.1	0.6	0.4
EBIT [+]	-73.2	-81.7	-53.3	-51.1	-21.2	-14.2
EBIT growth	-10.4%	53.3%	4.3%	141.2%	49.6%
EBIT margin	-513.4%	-442.7%	-272.1%	-427.8%	-277.6%
Interest expense, net [+]	-0.9	0.9	0.4	-0.7	0.8	0.6
Interest expense	0.7	0.9	0.8	0.9	0.8	0.6
Interest income	1.6	0.0	0.4	1.6
Other income (expense), net	7.5	6.9	9.6	7.3	5.7	2.0
Pre-tax income	-64.7	-75.7	-44.1	-43.0	-16.2	-12.7
Income taxes	0.2	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%
Net income	-64.9	-75.7	-44.1	-43.0	-16.2	-12.7
Net margin	-455.6%	-410.2%	-225.1%	-360.4%	-212.8%

Basic EPS [+]	($0.99)	($2.30)	($1.69)	($2.41)	($17.76)	($13.95)
Growth	-57.0%	36.1%	-29.7%	-86.4%	27.3%
Diluted EPS [+]	($0.99)	($2.30)	($1.69)	($2.41)	($17.76)	($13.95)
Growth	-57.0%	36.1%	-29.7%	-86.4%	27.3%

Shares outstanding (basic) [+]	65.5	32.8	26.0	17.9	0.9	0.9
Growth	99.5%	26.1%	45.8%	1853.2%	0.3%
Shares outstanding (diluted) [+]	65.5	32.8	26.0	17.9	0.9	0.9
Growth	99.5%	26.1%	45.8%	1853.2%	0.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.